FBC
BHVN icon

Fairfield, Bush & Co’s Biohaven BHVN Stock Holding History

Fairfield, Bush & Co’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-170
Closed -$7.28K – 146
2023
Q4 		$7.28K Buy
+170
New +$5.29K ﹤0.01% 331
2023
Q3 		– Sell
-125
Closed -$2.99K – 141
2023
Q2 		$2.99K Buy
+125
New +$2.15K ﹤0.01% 394

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fairfield, Bush & Co's BHVN Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Biohaven (BHVN) in Q1 2024, closing a stake of 170 shares — an estimated $7.28K sold.

Fairfield, Bush & Co first reported a position in BHVN in Q2 2023 and held it in 2 quarters. The position peaked at $7.28K in Q4 2023. 243 funds tracked by Wall St. Rank hold BHVN as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Biohaven position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 170 Biohaven shares in Q1 2024, an estimated $7.28K.
  • Fairfield, Bush & Co first reported a position in Biohaven in Q2 2023 and held it in 2 quarters.
  • Fairfield, Bush & Co's Biohaven position peaked at $7.28K in Q4 2023.
  • 243 funds tracked by Wall St. Rank held Biohaven as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.